The announcement of Edwards Lifesciences’(NYSE:EW) second quarter fiscal 2011 results as on July 21, 2011, has led analysts to revise their estimates lower for the third quarter. Previous Quarter Highlights Edwards reported an adjusted EPS of 49 cents in the second quarter of fiscal 2011, a penny below the Zacks Consensus Estimate, although exceeding the year-ago [...]